Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials

As the Trump administration erodes U.S. | As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans to pull away from late-stage clinical trial investments in the area.

Jan 23, 2026 - 23:00
 0  18
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
As the Trump administration erodes U.S. | As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans to pull away from late-stage clinical trial investments in the area.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow